Fludrocortisone Plus Hydrocortisone Versus Hydrocortisone Alone as Adjunctive Therapy in Septic Shock: A Retrospective Cohort Study

被引:1
作者
Lock, Ashley. E. E. [1 ,2 ,3 ,4 ,5 ,9 ,10 ]
Gutierrez, G. Christina [1 ,2 ,3 ,4 ]
Hand, Elizabeth. O. O. [1 ,2 ,3 ,4 ]
Barthol, Colleen. A. A. [1 ,2 ,3 ,4 ]
Attridge, Rebecca. L. L. [6 ,7 ,8 ]
机构
[1] Univ Hlth San Antonio, Dept Pharmacotherapy, San Antonio, TX USA
[2] Univ Hlth San Antonio, Pharm Serv, San Antonio, TX USA
[3] Univ Texas Austin, Coll Pharm, Div Pharmacotherapy, Austin, TX USA
[4] UT Hlth San Antonio, Pharmacotherapy Educ & Res Ctr, San Antonio, TX USA
[5] UT Hlth San Antonio, Long Sch Med, Dept Emergency Med, San Antonio, TX USA
[6] Univ Incarnate Word, Feik Sch Pharm, San Antonio, TX USA
[7] UT Hlth San Antonio, Div Pulm Dis & Crit Care, Dept Med, San Antonio, TX USA
[8] Craneware Grp, Deerfield Beach, FL USA
[9] Univ Hlth San Antonio, Dept Pharmacotherapy, 4502 Med Dr, MS 102-1, San Antonio, TX 78229 USA
[10] Univ Hlth San Antonio, Pharm Serv, 4502 Med Dr, MS 102-1, San Antonio, TX 78229 USA
关键词
corticosteroids; hydrocortisone; fludrocortisone; sepsis; septic shock; SURVIVING SEPSIS CAMPAIGN; LOW-DOSE HYDROCORTISONE; INTERNATIONAL GUIDELINES; CORTICOSTEROID TREATMENT; MANAGEMENT; VASOPRESSIN; MORTALITY; REVERSAL; ADULTS;
D O I
10.1177/10600280231164210
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Trials evaluating hydrocortisone (HC) for septic shock are conflicting with all finding decreased time to shock reversal but few with mortality difference. Those with improved mortality included fludrocortisone (FC), but it is unknown if FC affected the outcome or is coincidental as there are no comparative data. Objective: The objective of this study was to determine the effectiveness and safety of FC + HC versus HC alone as adjunctive therapy in septic shock. Methods: A single-center, retrospective cohort study was conducted of medical intensive care unit (ICU) patients with septic shock refractory to fluids and vasopressors. Patients receiving FC + HC were compared with those receiving HC. Primary outcome was time to shock reversal. Secondary outcomes included in-hospital, 28-, and 90-day mortality; ICU and hospital length of stay (LOS); and safety. Results: There were 251 patients included (FC + HC, n = 114 vs HC, n = 137). There was no difference in time to shock reversal (65.2 vs 71 hours; P = 0.24). Cox proportional hazards model showed time to first corticosteroid dose, full-dose HC duration, and use of FC + HC were associated with shorter shock duration, while time to vasopressor therapy was not. However, in 2 multivariable models controlling for covariates, use of FC + HC was not an independent predictor of shock reversal at greater than 72 hours and in-hospital mortality. No differences were seen in hospital LOS or mortality. Hyperglycemia occurred more frequently with FC + HC (62.3% vs 45.6%; P = 0.01). Conclusion and Relevance: FC + HC was not associated with shock reversal at greater than 72 hours or decreased in-hospital mortality. These data may be useful for determining corticosteroid regimen in patients with septic shock refractory to fluids and vasopressors. Future prospective, randomized studies are needed to further evaluate the role of FC in this patient population.
引用
收藏
页码:1375 / 1388
页数:14
相关论文
共 28 条
[11]   Corticosteroids in septic shock: a systematic review and network meta-analysis [J].
Gibbison, Ben ;
Lopez-Lopez, Jose A. ;
Higgins, Julian P. T. ;
Miller, Tom ;
Angelini, Gianni D. ;
Lightman, Stafford L. ;
Annane, Djillali .
CRITICAL CARE, 2017, 21
[12]   Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock The VANISH Randomized Clinical Trial [J].
Gordon, Anthony C. ;
Mason, Alexina J. ;
Thirunavukkarasu, Neeraja ;
Perkins, Gavin D. ;
Cecconi, Maurizio ;
Cepkova, Magda ;
Pogson, David G. ;
Aya, Hollmann D. ;
Anjum, Aisha ;
Frazier, Gregory J. ;
Santhakumaran, Shalini ;
Ashby, Deborah ;
Brett, Stephen J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (05) :509-518
[13]   Management of Refractory Vasodilatory Shock [J].
Jentzer, Jacob C. ;
Vallabhajosyula, Saraschandra ;
Khanna, Ashish K. ;
Chawla, Lakhmir S. ;
Busse, Laurence W. ;
Kashani, Kianoush B. .
CHEST, 2018, 154 (02) :416-426
[14]   Early Administration of Hydrocortisone Replacement After the Advent of Septic Shock: Impact on Survival and Immune Response [J].
Katsenos, Chrysostomos S. ;
Antonopoulou, Anastasia N. ;
Apostolidou, Efterpi N. ;
Ioakeimidou, Aikaterini ;
Kalpakou, Georgia Th. ;
Papanikolaou, Metaxia N. ;
Pistiki, Aikaterini C. ;
Mpalla, Margarita C. ;
Paraschos, Michael D. ;
Patrani, Maria A. ;
Pratikaki, Maria E. ;
Retsas, Theodoros A. ;
Savva, Athina A. ;
Vassiliagkou, Spyridoula D. ;
Lekkou, Alexandra A. ;
Dimopoulou, Ioanna ;
Routsi, Christina ;
Mandragos, Konstantinos E. .
CRITICAL CARE MEDICINE, 2014, 42 (07) :1651-1657
[15]   The SOFA score-development, utility and challenges of accurate assessment in clinical trials [J].
Lambden, Simon ;
Laterre, Pierre Francois ;
Levy, Mitchell M. ;
Francois, Bruno .
CRITICAL CARE, 2019, 23 (01)
[16]   Impact and Beneficial Critical Points of Clinical Outcome in Corticosteroid Management of Adult Patients With Sepsis: Meta-Analysis and GRADE Assessment [J].
Lin, Lu-Lu ;
Gu, Hui-Yun ;
Luo, Jie ;
Wang, Long ;
Zhang, Chao ;
Niu, Yu-Ming ;
Zuo, Hong-Xia .
FRONTIERS IN PHARMACOLOGY, 2019, 10
[17]   Effect of Low-Dose Hydrocortisone Therapy in Adult Patients With Septic Shock: A Meta-Analysis With Trial Sequential Analysis of Randomized Controlled Trials [J].
Lyu, Qing-Quan ;
Chen, Qi-Hong ;
Zheng, Rui-Qiang ;
Yu, Jiang-Quan ;
Gu, Xiao-Hua .
JOURNAL OF INTENSIVE CARE MEDICINE, 2020, 35 (10) :971-983
[18]   Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock [J].
Oppert, M ;
Schindler, R ;
Husung, C ;
Offermann, K ;
Gräf, KJ ;
Boenisch, O ;
Barckow, D ;
Frei, U ;
Eckardt, KU .
CRITICAL CARE MEDICINE, 2005, 33 (11) :2457-2464
[19]   Pharmacokinetics of oral fludrocortisone in septic shock [J].
Polito, Andrea ;
Hamitouche, Noureddine ;
Ribot, Megane ;
Polito, Angelo ;
Laviolle, Bruno ;
Bellissant, Eric ;
Annane, Djillali ;
Alvarez, Jean-Claude .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (06) :1509-1516
[20]   Comparison of Early Versus Late Initiation of Hydrocortisone in Patients With Septic Shock in the ICU Setting [J].
Ragoonanan, David ;
Allen, Bryan ;
Cannon, Chad ;
Rottman-Pietrzak, Kathleen ;
Bello, Abdel .
ANNALS OF PHARMACOTHERAPY, 2022, 56 (03) :264-270